Should You Be Adding Sam-A Pharm To Your Watchlist Today?
| HURA Stock | 5.78 0.15 2.53% |
About 61% of TuHURA Biosciences' investor base is looking to short. The analysis of overall sentiment of trading TuHURA Biosciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with TuHURA Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use TuHURA Biosciences stock news signals to limit their universe of possible portfolio assets.
TuHURA |
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Read at simplywall.st
 |
TuHURA Biosciences Fundamental Analysis
We analyze TuHURA Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TuHURA Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TuHURA Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
TuHURA Biosciences is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
TuHURA Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TuHURA Biosciences stock to make a market-neutral strategy. Peer analysis of TuHURA Biosciences could also be used in its relative valuation, which is a method of valuing TuHURA Biosciences by comparing valuation metrics with similar companies.
Peers
TuHURA Biosciences Related Equities
| VKTX | Viking Therapeutics | 2.84 | ||||
| VNDA | Vanda Pharmaceuticals | 1.52 | ||||
| VRNA | Verona Pharma | 1.29 | ||||
| VRTX | Vertex Pharmaceuticals | 0.20 | ||||
| VRCA | Verrica Pharmaceuticals | 1.14 | ||||
| VSTM | Verastem | 1.80 | ||||
| VRDN | Viridian Therapeutics | 1.96 | ||||
| DWTX | Dogwood Therapeutics, | 2.55 | ||||
| VTGN | VistaGen Therapeutics | 3.09 | ||||
| VRPX | Virpax Pharmaceuticals | 3.13 |
Complementary Tools for TuHURA Stock analysis
When running TuHURA Biosciences' price analysis, check to measure TuHURA Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TuHURA Biosciences is operating at the current time. Most of TuHURA Biosciences' value examination focuses on studying past and present price action to predict the probability of TuHURA Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TuHURA Biosciences' price. Additionally, you may evaluate how the addition of TuHURA Biosciences to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |